Pan-kinase inhibitor for head and neck cancer enters clinical trials

by | Mar 18, 2025 | Clinical Trials | 0 comments

​ 

A drug targeting the scaffolding function of multiple related kinases halts tumor progression.

 A drug targeting the scaffolding function of multiple related kinases halts tumor progression. 

Submit a Comment

Your email address will not be published. Required fields are marked *